Hamamatsu Photonics (6965) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for the nine months ended June 30, 2024, were JPY 150,548 million, down 8.5% year-over-year, with operating profit down 41.1% and profit attributable to owners of parent down 37.1%.
Decreases in sales and earnings were attributed to post-COVID demand normalization, inventory adjustments, and weaker demand in medical and industrial fields.
The company revised its full-year forecast downward, expecting net sales of JPY 205,700 million and profit attributable to owners of parent of JPY 24,900 million.
Financial highlights
Operating profit for the nine months was JPY 25,302 million, down 41.1% year-over-year; ordinary profit was JPY 27,911 million, down 37.7%.
Earnings per share for the nine months was JPY 131.80, compared to JPY 209.70 in the prior year period.
Gross profit margin declined as gross profit fell to JPY 76,407 million from JPY 89,413 million year-over-year.
Comprehensive income for the nine months was JPY 29,484 million, down 17.6% year-over-year.
Outlook and guidance
Full-year forecast revised downward: net sales JPY 205,700 million (down 2.6% from previous forecast), operating profit JPY 32,000 million (down 14.7%), and EPS JPY 160.78.
Earnings expected to fall below previous guidance due to greater-than-expected inventory adjustments and end of COVID-19 special demand.
Recovery in sales anticipated for fiscal year ending September 2025 based on current market and order trends.
Latest events from Hamamatsu Photonics
- Sales up 2.6%, profit down 43.9% on costs; guidance steady, buyback ongoing.6965
Q1 20266 Feb 2026 - Sales grew 4% but profits dropped sharply; modest recovery and tech focus ahead.6965
Q4 202510 Nov 2025 - Q1 FY25 profit and sales fell, but full-year guidance and share buyback remain unchanged.6965
Q1 202510 Sep 2025 - Sales up, profits down sharply; full-year outlook cut amid persistent market challenges.6965
Q3 20258 Aug 2025 - Sales to recover in FY25, with profits pressured by upfront investments for future growth.6965
Q4 202413 Jun 2025 - Sales up, profits down; outlook steady as recovery and cost pressures persist.6965
Q2 20256 Jun 2025